PitchBook's Auricle (Therapeutic Devices) profile labeled the company 'Out of Business'; that conflicts with later NIH/LinkedIn evidence and a 2024 SBIR award, so the status is unresolved.
SourceNeurostimulation implant to restore hearing & speech understanding
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Auricle is an early-stage medical device company from Stanford Biodesign developing a reversible, less invasive neurostimulation implant for sensorineural hearing loss. Public sources agree on a 2020 founding and Mountain View HQ, but funding figures vary across databases ($625k reported by LinkedIn vs. $850k on Caplight).
Primary product
Neurostimulation implant for hearing restoration
Founded
2020
Headquarters
Mountain View, California, United States
Team size
1-10 employees
Industry
Medical Equipment Manufacturing
Sub-industry
Hearing-restoration neurostimulation devices
Offices
0 jobs at Auricle
Check back later for new openings
Business model
Stage
seed
Total raised
$625K
Latest round
Accelerator · Apr 2023
Apr 2023
Aug 2021
Mar 2021
Apr 2020
Leadership
Co-founder & CEO
Co-founder & CTO
Vice President of Engineering
Investors
Mission-driven, Stanford Biodesign-rooted team focused on restoring hearing with a less invasive implant and advancing it through clinical and preclinical work.
Compensation
The public YC job listing showed a Founding Biomedical Engineer role with $100K-$180K salary and 0.50%-10.00% equity; no broader public compensation policy was found.
Differentiators
Technology
Customers
Competitors
Estimated revenue
USD 1M-10M
Estimated monthly visits
4.5K
Traffic estimate as of Apr 2026
PitchBook's Auricle (Therapeutic Devices) profile labeled the company 'Out of Business'; that conflicts with later NIH/LinkedIn evidence and a 2024 SBIR award, so the status is unresolved.
SourceSBIR / NIH · Aug 2024
Official SBIR Phase I award notice for Auricle Health Inc. with a $275,371 award and project dates from 2024-08-01 to 2025-07-31.
NIH RePORTER · Jul 2024
Official NIH project record for the same hearing-restoration device effort, naming Francis Wong as project leader and confirming the project scope and funding.
TechCrunch · Apr 2023
Mentions Auricle as a reversible surgery and implant to restore hearing as an alternative to cochlear implants, highlighting both the opportunity and the technical risk.
Fogarty Innovation · Aug 2020
Early profile of Auricle's origins at Stanford Biodesign, naming Francis Wong and Jay Dhuldhoya and describing the clinical problem and proposed minimally invasive approach.
Stanford Medicine
Stanford Biodesign story describing Auricle's hearing-loss project, the clinical motivation, and the team's early clinical study and proof-of-concept work.